查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825968

2025年恒溫核酸增幅技術（INAAT）全球市場報告

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，恒溫核酸增幅技術 (INAAT) 市場快速擴張，從 2024 年的 39.4 億美元成長到 2025 年的 43.3 億美元，複合年成長率為 10.0%。預測期內的成長將由感染疾病診斷、就地檢驗(POCT)、結核病控制、分子診斷和新興市場推動。

預計未來幾年，恒溫核酸增幅技術 (INAAT) 市場將快速成長，到 2029 年將達到 74.4 億美元，複合年成長率為 14.5%。預測期內的成長可歸因於疫情應對措施、抗生素抗藥性、環境監測、腫瘤診斷和全球衛生計劃。預測期內的主要趨勢包括連接複用、微型化、數位檢測、樣本到結果系統以及基因編輯整合。

恒溫核酸增幅技術 (INAAT) 是一種用於擴增 DNA 樣本的方法。 INAAT 允許在恆定溫度下擴增來自兩個不同核酸片段的 DNA 序列。

與恒溫核酸增幅技術相關的主要產品類型包括儀器和試劑。試劑是指引入系統以誘導化學反應或確定反應是否發生的物質或化合物。 NASBA 和 HAD 等各種技術通常用於血液篩檢、感染疾病診斷和癌症相關分析等領域。該技術的最終用戶是醫院、參考實驗室和其他機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供恒溫核酸增幅技術 (INAAT) 市場統計數據，例如全球市場規模、各地區佔有率、競爭對手的恒溫核酸增幅恒溫核酸增幅技術 (INAAT) 市場佔有率、詳細的恒溫核酸增幅恒溫核酸增幅(INAAT) 細分市場、市場、市場和市場成功，以及您在市場等產業成功的全球階段 (INAAT) 市場、市場、市場本恒溫核酸增幅技術 (INAAT) 市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年14.5%的成長預測比我們先前的預測略有下降0.2%。這一下降主要歸因於美國與其他國家之間關稅的影響。關稅上漲可能會對美國診斷實驗室造成壓力，因為它會增加從新加坡和韓國採購的可攜式INAAT檢測平台和試劑的成本，加劇就地檢驗的延誤，並增加傳染病篩檢的成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

感染疾病和慢性病的日益普及是恒溫核酸增幅技術 (INAAT) 市場擴張的關鍵驅動力。流感嗜血桿菌、肺炎鏈球菌（呼吸道感染疾病）、淋病奈瑟菌、沙眼衣原體（生殖器感染疾病）和結核病 (TB) 等疾病的增多，需要恒溫核酸增幅技術 (INAAT) 等診斷解決方案。根據世界衛生組織 (WHO) 統計，全球每年約有 1000 萬人感染結核病，導致 150 萬人死亡。感染疾病和慢性病的日益普及正刺激恒溫核酸增幅技術市場的擴張。

政府針對醫療保健研究和開發的舉措預計將顯著促進恒溫核酸增幅技術市場的未來成長。這些舉措包括政府機構為解決各種醫療保健問題而採取的具體行動、計劃和措施，包括對恒溫核酸增幅技術的支援。 2022 年，英國衛生和社會保障部 (DHSC) 宣布承諾提供 2.6 億英鎊（2.7065 億美元）的資金，以促進醫療保健研究和製造。該資金由商業、能源和工業戰略部 (BEIS) 和 DHSC 設立，旨在促進 NHS主導的醫學研究、保護隱私的診斷和治療平台，並加強英國的生命科學製造業。因此，政府專注於醫療保健研究和開發的措施正在推動恒溫核酸增幅技術市場的發展。

奈米結構擴大被應用於體外診斷和快速診斷檢測 (RDT)，以提高現有檢測的有效性，並開發用於照護現場應用的創新診斷方法。奈米結構和奈米技術利用奈米粒子來改善治療環境中的藥物作用。奈米技術是透過在奈米尺度上精確操控尺寸和形態來設計、表徵、製造和應用設備、結構和系統。目前已發展出多種梅毒診斷的 RDT，包括 AccuBioTech（Accu-Tell 快速梅毒檢測）、Alere, Inc.（Alere Determine）、Alere/Standard Diagnostics（SD Syphilis 3.0）、The Tulip Group/Qualpro（Syphicheck-WB）、Cypress Diagnostics（Syphpress）快速檢測）。這些 RDT 使患者能夠在即時診斷 (POC) 時獲得診斷。

恒溫核酸增幅技術市場的主要企業正在率先推出像 QIAstat-Dx 症候群檢測解決方案這樣的創新解決方案，以獲得競爭優勢。 QIAstat-Dx 系統是一個整合的多重分子檢測平台，可在單一試劑盒中完成樣品製備、核酸擴增和檢測。例如，2023 年 4 月，總部位於荷蘭、專注於為各種應用提供恒溫核酸增幅技術 (INAAT) 的公司 Qiagen 推出了 QIAstat-Dx 症候群檢測解決方案。該系統提供 Ct（循環閾值）值和擴增曲線，使臨床醫生能夠監測擴增進展並做出明智的診斷決策。

2023年2月，美國生技公司Sherlock Biosciences收購了Sense Biodetection，收購金額未揭露。此次收購將使Sherlock能夠透過將Sense基於LAMP的技術與先進的CRISPR方法結合，增強其診斷能力，從而提高分子檢測的速度和可及性。總部位於英國的Sense Biodetection專注於利用恒溫核酸增幅技術（尤其是環介導等溫擴增技術，LAMP）開發快速的照護現場診斷解決方案。

恒溫核酸增幅技術 (INAAT) 市場的主要企業包括 Alere Inc.、biomeriux SA、Qiagen NV、Becton、Dickson & Company、Hologica Inc.、Lucigen Corporation、Quidel Corporation、New England Biolabs Inc.、NuTech、Ustar BIoTechnologies Ltd.、ThemoBiopell Ltd. Corporation、Sony Corporation、Panasonic Holdings Corporation、Toshiba Corporation、Rohm Co Ltd.、PhilipsHologic-Gen-Probe、BetaLED、Avago Technologies Ltd.、Grifols SA、Abbott Laboratories、Jena Bioscience GmbH、Atila Biosystems Incorporated、TwistDx Ltd.、LGC Ltd.、DiaGene)。

2024年，恒溫核酸增幅技術 (INAAT) 市場最大的地區是北美。西歐是恒溫核酸增幅技術 (INAAT) 市場的第二大地區。恒溫核酸增幅技術 (INAAT) 市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

恒溫核酸增幅技術（INAAT）市場報告涵蓋國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙、加拿大

恒溫核酸增幅技術 (INAAT) 市場包括反應系統及相關服務的收益。市場規模包括服務供應商銷售或包含在服務產品中的相關產品的價值。它僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球恒溫核酸增幅技術（INAAT）：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球恒溫核酸增幅技術（INAAT）市場：成長率分析
  • 全球恒溫核酸增幅技術 (INAAT) 市場表現：規模與成長，2019-2024 年
  • 全球恒溫核酸增幅技術 (INAAT) 市場預測：規模與成長，2024-2029 年，2034 年
  • 全球恒溫核酸增幅技術（INAAT）：總目標市場（TAM）

第6章 市場細分

  • 全球恒溫核酸增幅技術（INAAT）市場（依產品、效能及預測），2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑
  • 全球恒溫核酸增幅技術（INAAT）市場技術、效能及預測（2019-2024、2024-2029、2034）
  • NASBA
  • HAD
  • 全球恒溫核酸增幅技術（INAAT）市場的應用、效能與預測，2019-2024年、2024-2029年、2034年
  • 血液檢查
  • 感染疾病診斷
  • 癌症
  • 全球恒溫核酸增幅技術 (INAAT) 市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 參考實驗室
  • 其他
  • 全球恒溫核酸增幅技術（INAAT）市場：儀器細分、類型、效能及預測，2019-2024年、2024-2029年、2034年
  • 可攜式設備
  • 桌上型裝置
  • 全球恒溫核酸增幅技術（INAAT）市場：試劑細分、類型、效能及預測，2019-2024年、2024-2029年、2034年
  • 酵素
  • 引子和探針
  • 緩衝液和其他試劑

第7章 區域和國家分析

  • 全球恒溫核酸增幅技術（INAAT）市場各地區、績效及預測（2019-2024年、2024-2029年、2034年）
  • 全球恒溫核酸增幅技術（INAAT）市場（依國家、績效及預測），2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 恒溫核酸增幅技術（INAAT）市場：競爭格局
  • 恒溫核酸增幅技術（INAAT）市場：公司簡介
    • Alere Inc.
    • biomeriux SA
    • Qiagen NV
    • Becton, Dickson & Company
    • Hologica Inc.

第31章：其他領先和創新企業

  • Lucigen Corporation
  • Quidel Corporation
  • New England Biolabs Inc.
  • NuGen
  • Ustar BIoTechnologies Ltd.
  • Thermo Fisher Scientific Inc.
  • BioHelix Corporation
  • Meridian Bioscience Inc.
  • Novartis AG
  • Sharp Corporation
  • Sony Corporation
  • Panasonic Holdings Corporation
  • Toshiba Corporation
  • Rohm Co Ltd.
  • PhilipsHologic-Gen-Probe

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年恒溫核酸增幅技術（INAAT）市場：提供新機會的國家
  • 恒溫核酸增幅技術 (INAAT) 市場，2029 年：提供新機會的細分市場
  • 恒溫核酸增幅技術（INAAT）市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32621u

Isothermal nucleic acid amplification technology (INAAT) is a method employed for amplifying DNA samples. INAAT enables the amplification of DNA sequences from two different nucleic acid segments at a constant temperature.

The primary product types associated with isothermal nucleic acid amplification technology include instruments and reagents. Reagents are substances or compounds introduced into a system to induce a chemical reaction or to determine whether a reaction has occurred. Various technologies, such as NASBA and HAD, are used in this context and are typically applied in areas like blood screening, infectious disease diagnostics, and cancer-related analyses. The end users of this technology encompass hospitals, reference laboratories, and other institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The isothermal nucleic acid amplification technology (INAAT) market research report is one of a series of new reports from The Business Research Company that provides isothermal nucleic acid amplification technology (INAAT) market statistics, including isothermal nucleic acid amplification technology (INAAT) industry global market size, regional shares, competitors with a isothermal nucleic acid amplification technology (INAAT) market share, detailed isothermal nucleic acid amplification technology (INAAT) market segments, market trends and opportunities, and any further data you may need to thrive in the isothermal nucleic acid amplification technology (INAAT) industry. This isothermal nucleic acid amplification technology (INAAT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isothermal nucleic acid amplification technology (inaat) market size has grown rapidly in recent years. It will grow from $3.94 billion in 2024 to $4.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to infectious disease diagnostics, point-of-care testing (poct), tuberculosis control, molecular diagnostics, emerging markets.

The isothermal nucleic acid amplification technology (inaat) market size is expected to see rapid growth in the next few years. It will grow to $7.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to pandemic preparedness, antimicrobial resistance, environmental monitoring, oncology diagnostics, global health initiatives. Major trends in the forecast period include multiplexing, miniaturization, digital detection, sample-to-answer systems, gene editing integration.

The forecast of 14.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. diagnostic labs by driving up the cost of portable INAAT testing platforms and reagents sourced from Singapore and South Korea, exacerbating point-of-care testing delays and increasing infectious disease screening costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of Infectious and Chronic Diseases is a significant driver behind the expansion of the Isothermal Nucleic Acid Amplification Technology (INAAT) market. Diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are on the increase, demanding diagnostic solutions like isothermal nucleic acid amplification technology (INAAT). According to the World Health Organization (WHO), an estimated 10 million people contract tuberculosis every year, resulting in 1.5 million deaths. The growing prevalence of infectious and chronic diseases is a key factor fueling the expansion of the isothermal nucleic acid amplification technology market.

Government initiatives aimed at healthcare research and development are poised to significantly drive the growth of the isothermal nucleic acid amplification technology market in the future. These initiatives involve specific actions, programs, or policies launched by government entities to tackle various healthcare issues, including supporting isothermal nucleic acid amplification technology. In 2022, the UK's Department of Health and Social Care (DHSC) announced a £260 million ($270.65 million) funding commitment to foster healthcare research and manufacturing. This funding, established by the Department for Business, Energy and Industrial Strategy (BEIS) and DHSC, aims to facilitate NHS-led health research, privacy-preserving platforms for diagnostics and treatments, and bolster life sciences manufacturing in the UK. Hence, government initiatives focused on healthcare research and development are propelling the isothermal nucleic acid amplification technology market.

Nanostructures are increasingly integrated into in vitro diagnostics and in vitro rapid diagnostic tests (RDTs) to enhance existing tests' effectiveness and develop innovative diagnostic approaches for point-of-care applications. Nanostructures and nanotechnology employ nanoparticles to improve drug actions in treatments. Nanotechnology entails designing, characterizing, producing, and applying devices, structures, and systems by precisely manipulating size and shape at the nanometer scale. Several RDTs have been created for syphilis diagnosis, such as AccuBioTech (Accu-Tell Rapid Syphilis Test), Alere, Inc. (Alere Determine), Alere/Standard Diagnostics (SD Syphilis 3.0), The Tulip Group/Qualpro (Syphicheck - WB), Cypress Diagnostics (Syphilis Rapid Test), and Omega Diagnostics (Visitect Syphilis). These RDTs enable patients to receive diagnoses at the point of care (POC).

Major companies operating in the isothermal nucleic acid amplification technology market are developing innovative solutions like the QIAstat-Dx syndromic testing solution to gain a competitive advantage. The QIAstat-Dx system is an integrated, multiplexed molecular testing platform that combines sample preparation, nucleic acid amplification, and detection within a single cartridge. For instance, in April 2023, Qiagen, a Netherlands-based company specializing in isothermal nucleic acid amplification technology (INAAT) for various applications, introduced the QIAstat-Dx syndromic testing solution. This system provides Ct (cycle threshold) values and access to amplification curves, allowing clinicians to monitor amplification progress and make well-informed diagnostic decisions.

In February 2023, Sherlock Biosciences, a U.S.-based biotechnology company, acquired Sense Biodetection for an undisclosed amount. This acquisition allows Sherlock to enhance its diagnostic capabilities by integrating Sense's LAMP-based technology with its advanced CRISPR methodologies, thereby improving the speed and accessibility of molecular testing. Sense Biodetection, a UK-based company, specializes in developing rapid, point-of-care diagnostic solutions that utilize isothermal nucleic acid amplification technology, particularly Loop-Mediated Isothermal Amplification (LAMP).

Major companies operating in the isothermal nucleic acid amplification technology (inaat) market include Alere Inc., biomeriux SA, Qiagen NV, Becton, Dickson & Company, Hologica Inc., Lucigen Corporation, Quidel Corporation, New England Biolabs Inc., NuGen, Ustar Biotechnologies Ltd., Thermo Fisher Scientific Inc., BioHelix Corporation, Meridian Bioscience Inc., Novartis AG, Sharp Corporation, Sony Corporation, Panasonic Holdings Corporation, Toshiba Corporation, Rohm Co Ltd., PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies Ltd., Grifols SA, Abbott Laboratories, Jena Bioscience GmbH, Atila Biosystems Incorporated, TwistDx Ltd., LGC Ltd., DiaSorin SpA, OptiGene Limited

North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2024. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the isothermal nucleic acid amplification technology (inaat) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The isothermal nucleic acid amplification technology (INAAT) market includes revenues earned by reaction systems and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isothermal nucleic acid amplification technology (inaat) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isothermal nucleic acid amplification technology (inaat) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The isothermal nucleic acid amplification technology (inaat) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instrument; Reagent
  • 2) By Technology: NASBA; HAD
  • 3) By Application: Blood Screening; Infectious Disease Diagnostics; Cancer
  • 4) By End-User: Hospital; Reference Laboratories; Other End-Users
  • Subsegments:
  • 1) By Instrument: Portable Instruments; Benchtop Instruments
  • 2) By Reagent: Enzymes; Primers And Probes; Buffers And Other Reagents
  • Companies Mentioned: Alere Inc.; biomeriux SA; Qiagen NV; Becton, Dickson & Company; Hologica Inc.; Lucigen Corporation; Quidel Corporation; New England Biolabs Inc.; NuGen; Ustar Biotechnologies Ltd.; Thermo Fisher Scientific Inc.; BioHelix Corporation; Meridian Bioscience Inc.; Novartis AG; Sharp Corporation; Sony Corporation; Panasonic Holdings Corporation; Toshiba Corporation; Rohm Co Ltd.; PhilipsHologic-Gen-Probe; BetaLED; Avago Technologies Ltd.; Grifols SA; Abbott Laboratories; Jena Bioscience GmbH; Atila Biosystems Incorporated; TwistDx Ltd.; LGC Ltd.; DiaSorin SpA; OptiGene Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Characteristics

3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends And Strategies

4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate Analysis
  • 5.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Total Addressable Market (TAM)

6. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation

  • 6.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instrument
  • Reagent
  • 6.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NASBA
  • HAD
  • 6.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • 6.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Reference Laboratories
  • Other End-Users
  • 6.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Instruments
  • Benchtop Instruments
  • 6.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzymes
  • Primers and Probes
  • Buffers and Other Reagents

7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Regional And Country Analysis

  • 7.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 8.1. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 9.1. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 9.2. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 10.1. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 11.1. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 11.2. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 12.1. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 13.1. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 14.1. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 14.2. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 15.1. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 15.2. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 16.1. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 17.1. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 18.1. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 19.1. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 20.1. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 21.1. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 21.2. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 22.1. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 23.1. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 23.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 24.1. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 24.2. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 25.1. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 25.2. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 26.1. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 26.2. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 27.1. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 28.1. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 28.2. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 29.1. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 29.2. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape And Company Profiles

  • 30.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape
  • 30.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Company Profiles
    • 30.2.1. Alere Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. biomeriux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickson & Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologica Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Other Major And Innovative Companies

  • 31.1. Lucigen Corporation
  • 31.2. Quidel Corporation
  • 31.3. New England Biolabs Inc.
  • 31.4. NuGen
  • 31.5. Ustar Biotechnologies Ltd.
  • 31.6. Thermo Fisher Scientific Inc.
  • 31.7. BioHelix Corporation
  • 31.8. Meridian Bioscience Inc.
  • 31.9. Novartis AG
  • 31.10. Sharp Corporation
  • 31.11. Sony Corporation
  • 31.12. Panasonic Holdings Corporation
  • 31.13. Toshiba Corporation
  • 31.14. Rohm Co Ltd.
  • 31.15. PhilipsHologic-Gen-Probe

32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

34. Recent Developments In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

35. Isothermal Nucleic Acid Amplification Technology (INAAT) Market High Potential Countries, Segments and Strategies

  • 35.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer